BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23722546)

  • 1. Genetic ablation of the fatty acid-binding protein FABP5 suppresses HER2-induced mammary tumorigenesis.
    Levi L; Lobo G; Doud MK; von Lintig J; Seachrist D; Tochtrop GP; Noy N
    Cancer Res; 2013 Aug; 73(15):4770-80. PubMed ID: 23722546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability.
    Powell CA; Nasser MW; Zhao H; Wochna JC; Zhang X; Shapiro C; Shilo K; Ganju RK
    Oncotarget; 2015 Mar; 6(8):6373-85. PubMed ID: 25779666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells.
    Thulasiraman P; McAndrews DJ; Mohiudddin IQ
    BMC Cancer; 2014 Sep; 14():724. PubMed ID: 25260874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid-binding protein 5 and PPARbeta/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growth.
    Kannan-Thulasiraman P; Seachrist DD; Mahabeleshwar GH; Jain MK; Noy N
    J Biol Chem; 2010 Jun; 285(25):19106-15. PubMed ID: 20424164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in the brain.
    Yu S; Levi L; Casadesus G; Kunos G; Noy N
    J Biol Chem; 2014 May; 289(18):12748-58. PubMed ID: 24644281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saturated fatty acids regulate retinoic acid signalling and suppress tumorigenesis by targeting fatty acid-binding protein 5.
    Levi L; Wang Z; Doud MK; Hazen SL; Noy N
    Nat Commun; 2015 Nov; 6():8794. PubMed ID: 26592976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual role of fatty acid-binding protein 5 on endothelial cell fate: a potential link between lipid metabolism and angiogenic responses.
    Yu CW; Liang X; Lipsky S; Karaaslan C; Kozakewich H; Hotamisligil GS; Bischoff J; Cataltepe S
    Angiogenesis; 2016 Jan; 19(1):95-106. PubMed ID: 26625874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR.
    Schug TT; Berry DC; Toshkov IA; Cheng L; Nikitin AY; Noy N
    Proc Natl Acad Sci U S A; 2008 May; 105(21):7546-51. PubMed ID: 18495924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of
    Wang W; Liu Z; Chen X; Lu Y; Wang B; Li F; Lu S; Zhou X
    DNA Cell Biol; 2021 Aug; 40(8):1076-1086. PubMed ID: 34160301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid induces neurogenesis by activating both retinoic acid receptors (RARs) and peroxisome proliferator-activated receptor β/δ (PPARβ/δ).
    Yu S; Levi L; Siegel R; Noy N
    J Biol Chem; 2012 Dec; 287(50):42195-205. PubMed ID: 23105114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice.
    Ma Z; Parris AB; Xiao Z; Howard EW; Kosanke SD; Feng X; Yang X
    J Exp Clin Cancer Res; 2017 Jan; 36(1):6. PubMed ID: 28061785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid-binding protein 5 controls microsomal prostaglandin E synthase 1 (mPGES-1) induction during inflammation.
    Bogdan D; Falcone J; Kanjiya MP; Park SH; Carbonetti G; Studholme K; Gomez M; Lu Y; Elmes MW; Smietalo N; Yan S; Ojima I; Puopolo M; Kaczocha M
    J Biol Chem; 2018 Apr; 293(14):5295-5306. PubMed ID: 29440395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells.
    Senga S; Kobayashi N; Kawaguchi K; Ando A; Fujii H
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1057-1067. PubMed ID: 29906613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
    Peng M; Ball-Kell SM; Tyner AL
    Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone Increases Blood-Brain Barrier Expression of Fatty Acid-Binding Protein 5 and Docosahexaenoic Acid Trafficking into the Brain.
    Low YL; Jin L; Morris ER; Pan Y; Nicolazzo JA
    Mol Pharm; 2020 Mar; 17(3):873-884. PubMed ID: 31944767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of retinoic acid sensitivity in pancreatic cancer.
    Gupta S; Pramanik D; Mukherjee R; Campbell NR; Elumalai S; de Wilde RF; Hong SM; Goggins MG; De Jesus-Acosta A; Laheru D; Maitra A
    Clin Cancer Res; 2012 Jan; 18(1):280-9. PubMed ID: 22010213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kruppel-like factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling.
    Zhang W; Levi L; Banerjee P; Jain M; Noy N
    Oncotarget; 2015 Nov; 6(34):35830-42. PubMed ID: 26416422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors.
    Schug TT; Berry DC; Shaw NS; Travis SN; Noy N
    Cell; 2007 May; 129(4):723-33. PubMed ID: 17512406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
    Borland MG; Khozoie C; Albrecht PP; Zhu B; Lee C; Lahoti TS; Gonzalez FJ; Peters JM
    Cell Signal; 2011 Dec; 23(12):2039-50. PubMed ID: 21843636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.